BUY Laurus Labs Ltd — Rahul Sharma, JM Financial
byRahul Sharma, JM FinancialHorizon: Intraday27 Jul 2026, 8:58 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Laurus Labs shares hit record high after multiple upgrades, but Kotak still sees 33% downside
NewsCnbc-Tv18·27 Jul · today
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
NewsEt-Markets·27 Jul · today
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·24 Jul · 2d ago
Laurus Labs Q1 Results: Stock jumps after margins cross 30%, other parameters beat
NewsCnbc-Tv18·24 Jul · 3d ago
Laurus Labs announced its Q1 FY27 financial results, reporting a revenue of ₹2,026 Cr, a 29% increase year-on-year. EBITDA stood at ₹644 Cr, up 66% with margins at 31.8%. The company highlighted stron
NSE · Press Release·24 Jul · 3d ago
Nifty in oversold territory; pullback to 24,000 possible: Analysts
NewsEt-Markets·27 Jul · today
Laurus Labs Limited has disclosed information regarding a composite scheme of arrangement involving its subsidiaries, Laurus Synthesis Private Limited and Sriam Labs Private Limited. The National Comp
BSE · Company Update·25 Jul · yesterday
Q1 Results Today Highlights: Tata Consumer con. PAT up 28.4%, ACC PAT declines 61.5%, Shriram Finance, Hindustan Zinc, SBI Life, SBI Cards, Laurus Labs Q1 profit rise
NewsHbl·24 Jul · 3d ago
Laurus Labs Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The press release is enclosed for information.
BSE · Company Update·24 Jul · 3d ago
Laurus Labs Ltd announced the approval of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved at a Board Meeting held on July 24,
BSE · Board Meeting·24 Jul · 3d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Laurus Labs
- BUY — Sachin Janardan Sarvade, IDBI Capital Markets and Securities16 Oct 2026 · ~3 months · target ₹2,400 · Active
- BUY — Shivangi Sarda, Motilal Oswal16 Oct 2026 · ~2 weeks · target ₹2,150 · SL hit
- BUY — Nuvama Wealth16 Oct 2026 · ~1 year · target ₹2,520 · Active
- BUY — Shivangi Sarda, Motilal Oswal13 Oct 2026 · ~3 months · target ₹2,100 · SL hit
- BUY — Ansh Jogendra Bhilwar13 Oct 2026 · ~2 weeks · target ₹2,155 · SL hit
More from Rahul Sharma, JM Financial
- BUY Syngene International21 Oct 2026 · ~2 weeks · target ₹440 · SL hit
- BUY Federal Bank21 Oct 2026 · ~2 weeks · target ₹360 · SL hit
- BUY State Bank of India19 Oct 2026 · ~3 months · target ₹1,050 · Active
- BUY Reliance Industries19 Oct 2026 · ~3 months · target ₹1,280 · Active
- BUY Maruti Suzuki India19 Oct 2026 · ~2 weeks · target ₹12,000 · Active

